参考文献/References:
[1] NGUYEN P H,RAMAMOORTHY A,SAHOO B R,et al.Amyloid oligomers:a joint experimental/computational perspective on Alzheimer's disease,Parkinson's disease,typeⅡdiabetes,and amyotrophic lateral sclerosis[J].Chem Rev,2021,121(4):2545-2647.
[2] KING P H.Skeletal muscle as a molecular and cellular biomarker of disease progression in amyotrophic lateral sclerosis:a narrative review[J].Neural Regen Res,2024,19(4):747-753.
[3] XU Z,CHEN J,WANG P,et al.The role of peripheral β-amyloid in insulin resistance,insulin secretion, and prediabetes:in vitro and population-based studies[J].Front Endocrinol(Lausanne),2023,14:1195658.
[4] DENGLER-CRISH C M,ELEFTERIOU F.Shared mechanisms:osteoporosis and Alzheimer's disease?[J].Aging(Albany NY),2019,11(5):1317-1318.
[5] LLABRE J E,GIL C,AMATYA N,et al.Degradation of bone quality in a transgenic mouse model of Alzheimer's disease[J].J Bone Miner Res,2022,37(12):2548-2565.
[6] SUN Y,LI J,XIE X,et al.Macrophage-osteoclast associ-ations:origin,polarization,and subgroups[J].Front Immunol,2021,12:778078.
[7] EL-MASRI B M,ANDREASEN C M,LAURSEN K S,et al.Mapping RANKL- and OPG-expressing cells in bone tissue:the bone surface cells as activators of osteoclastogenesis and promoters of the denosumab rebound effect[J].Bone Res,2024,12(1):62.
[8] DE LEON-OLIVA D,BARRENA-BL?ZQUEZ S,JIM?NEZ-?LVAREZ L,et al.The RANK-RANKL-OPG system:a multifaceted regulator of homeostasis,immunity,and cancer[J].Medicina(Kaunas),2023,59(10):1752.
[9] CHEN Y,XIAO H,LIU Z,et al.Sirt1:An increasingly interesting molecule with a potential role in bone metabolism and osteoporosis[J].Biomolecules,2024,14(8):970.
[10] UDAGAWA N,KOIDE M,NAKAMURA M,et al.Osteoclast differentiation by RANKL and OPG signaling pathways[J].J Bone Miner Metab,2021,39(1):19-26.
[11] BLANGY A,BOMPARD G,GUERIT D,et al.The osteoclast cytoskeleton-current understanding and therapeutic perspectives for osteoporosis[J].J Cell Sci,2020,133(13):jcs244798.
[12] UMUR E,BULUT S B,YIGIT P,et al.Exploring the role of hormones and cytokines in osteoporosis development[J].Biomedicines,2024,12(8):1830.
[13] MATSUMOTO N,SEKIYA M,SUN-WADA G H,et al.The lysosomal V-ATPase a3 subunit is involved in localization of Mon1-Ccz1,the GEF for Rab7,to secretory lysosomes in osteoclasts[J].Sci Rep,2022,12(1):8455.
[14] CHENG X,TIAN W,YANG J,et al.Engineering approaches to manipulate osteoclast behavior for bone regener-ation[J].Mater Today Bio,2024,26:101043.
[15] CUI S,XIONG F,HONG Y,et al.APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner[J].J Bone Miner Res,2011,26(5):1084-1098.
[16] XU C,ZHAO L,DONG C.A review of application of Aβ42/40 ratio in diagnosis and prognosis of Alzheimer's disease[J].J Alzheimers Dis,2022,90(2):495-512.
[17] LI S,YANG B,TEGUH D,et al.Amyloid β peptide enhances RANKL-induced osteoclast activation through NF-κB,ERK,and calcium oscillation signaling[J].Int J Mol Sci,2016,17(10):1683.
[18] ALIPRANTIS A O,UEKI Y,SULYANTO R,et al.NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism[J].J Clin Invest,2008,118(11):3775-3789.
[19] XU S,CAO X,YU Z,et al.Nicorandil Inhibits osteoclast formation base on NF-κB and p-38 MAPK signaling pathways and relieves ovariectomy-induced bone loss[J].Front Pharmacol,2021,12:726361.
[20] YANG X,ZENG J,XIE K,et al.Advanced glycation end product-modified low-density lipoprotein promotes pro-osteogenic reprogramming via RAGE/NF-κB pathway and exaggerates aortic valve calcification in hamsters[J].Mol Med, 2024,30(1):76.
[21] ZHOU J,LIU S,BI S,et al.The RAGE signaling in osteoporosis[J].Biomed Pharmacother,2023,165:115044.
[22] LIU J,TING J P,AL-AZZAM S,et al.Therapeutic advances in diabetes,autoimmune,and neurological diseases[J].Int J Mol Sci,2021,22(6):2805.
[23] ZHOU Z,IMMEL D,XI C X,et al.Regulation of osteoclast function and bone mass by RAGE[J].J Exp Med,2006,203(4):1067-1080.
[24] LIU T,WANG Y,QIAN B,et al.Potential metabolic pathways involved in osteoporosis and evaluation of fracture risk in individuals with diabetes[J].Biomed Res Int,2024,2024:6640796.
[25] JIANG T,XIA T,QIAO F,et al.Role and regulation of transcription factors in osteoclastogenesis[J].Int J Mol Sci,2023,24(22):16175.
[26] FEDELE E.Anti-amyloid therapies for Alzheimer's disease and the amyloid cascade hypothesis[J].Int J Mol Sci,2023,24(19):14499.
[27] MATSUO K,IRIE N.Osteoclast-osteoblast communica-tion[J].Arch Biochem Biophys,2008,473(2):201-209.
[28] HART N H,NEWTON R U,TAN J,et al.Biological basis of bone strength: anatomy, physiology and measurement[J].J Musculoskelet Neuronal Interact,2020,20(3):347-371.
[29] PAN J X,TANG F,XIONG F,et al.APP promotes osteoblast survival and bone formation by regulating mitochon-drial function and preventing oxidative stress[J].Cell Death Dis,2018,9(11):1077.
[30] XIA W F,JUNG J U,SHUN C,et al.Swedish mutant APP suppresses osteoblast differentiation and causes osteoporotic deficit,which are ameliorated by N-acetyl-L-cysteine[J].J Bone Miner Res,2013,28(10):2122-2135.
[31] MCGRATH C,LITTLE-LETSINGER S E,SANKARAN J S,et al.Exercise increases bone in SEIPIN deficient lipodystrophy,despite low marrow adiposity[J].Front Endocrinol(Lausanne),2021,12:782194.
[32] LABUSCA L.Adipose tissue in bone regeneration-stem cell source and beyond[J].World J Stem Cells,2022,14(6):372-392.
[33] PETRINA M,MARTIN J,BASTA S.Granulocyte macrophage colony-stimulating factor has come of age:from a vaccine adjuvant to antiviral immunotherapy[J].Cytokine Growth Factor Rev,2021,59:101-110.
[34] ROBLING A G,BONEWALD L F.The osteocyte:new insights[J].Annu Rev Physiol,2020,82:485-506.
[35] SHEN L,HU G,KARNER C M.Bioenergetic metabolism in osteoblast differentiation[J].Curr Osteoporos Rep,2022,20(1):53-64.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):7.
[3]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):12.
[4]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[5]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):27.
[6]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(03):19.
[7]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(03):20.
[8]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):5.
[9]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):21.
[10]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(03):16.